Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus alone versus low-dose tacrolimus plus sirolimus after primary liver transplantation
2009-017843-32Phase 3Completed
- Sponsor
- Foundation for Liver Research
- Start
- Jul 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial comparing Standard-dose extended-release tacrolimus with Low-dose extended-release tacrolimus plus low-dose sirolimus (2 arms). Primary endpoint: Percentage of patients with cGFR < 60 mL/min at 36 months after transplantation. Started Jul 2010; status: completed.
02
Drugs
tacrolimussirolimus
Beyond the preview
Go deeper on 2009-017843-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017843-32.